The prevalence of the autoimmune markers in chronic hepatitis - C patients and their impact on treatment by interferon and clinical profile / Yousef Salah Swify Ali ; Supervised Mazen Ibrahim Naga , Mervat Mohamed Elansary , Abd El razek Ahmed Mohamed

By:

Yousef Salah Swify Ali

Contributor(s):

Language: Eng Publication details: Cairo : Yousef Salah Swify Ali , 2005Description: 180p : charts ; 25cmOther title:

معدلات انتشار دالات المناعة الذاتية فى مرضى الالتهاب الكبدى المزمن الفيروسىجوتأثيرها على العلاج بعقار الانترفيرون و الحالة الاكلينيكية [Added title page title]

Subject(s):

Available additional physical forms:

Issued also as CD

Dissertation note: Thesis (PH.D.) - Cairo University - Faculty Of Medicine - Department Of Internal Medicine Summary: Alfa interferon is the first therapy for chronic hepatitis - C , and it was reported that autoimmune hepatitis could be triggered and exacerbated during interferon therapy

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Status	Date due	Barcode
Thesis	قاعة الرسائل الجامعية - الدور الاول	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.11.18.Ph.D.2005.Yo.P. (Browse shelf(Opens below))	Not for loan		01010110044246000
CD - Rom	مخـــزن الرســائل الجـــامعية - البدروم	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.11.18.Ph.D.2005.Yo.P. (Browse shelf(Opens below))	Not for loan		01020110044246000

Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	Cai01.11.18.Ph.D.2005.Mo.S. Study of non - symptomatizing patients with positive anti - HCV antibodies /	Cai01.11.18.Ph.D.2005.Mo.S. Study of non - symptomatizing patients with positive anti - HCV antibodies /	Cai01.11.18.Ph.D.2005.Yo.P. The prevalence of the autoimmune markers in chronic hepatitis - C patients and their impact on treatment by interferon and clinical profile /	Cai01.11.18.Ph.D.2005.Yo.P. The prevalence of the autoimmune markers in chronic hepatitis - C patients and their impact on treatment by interferon and clinical profile /	Cai01.11.18.Ph.D.2006.Eb.A. Assessment of hepatic arterial buffer response by transcutaneous duplex Doppler sonography in large hepatoceuular carcinoma /	Cai01.11.18.Ph.D.2006.Eb.A. Assessment of hepatic arterial buffer response by transcutaneous duplex Doppler sonography in large hepatoceuular carcinoma /	Cai01.11.18.Ph.D.2006.Mo.E. Effect of low - dose l - thyroxine and lacidipine as vasodilators on the microcirculation in systemic lupus erythematosus /	Next

Thesis (PH.D.) - Cairo University - Faculty Of Medicine - Department Of Internal Medicine

Alfa interferon is the first therapy for chronic hepatitis - C , and it was reported that autoimmune hepatitis could be triggered and exacerbated during interferon therapy

Issued also as CD

There are no comments on this title.

to post a comment.